OAC
LXRX icon

OMERS Administration Corp’s Lexicon Pharmaceuticals LXRX Stock Holding History

OMERS Administration Corp’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$167K Sell
106,800
-167,000
-61% -$243K ﹤0.01% 948
2025
Q4 		$315K Buy
+273,800
New +$376K ﹤0.01% 801

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OMERS Administration Corp's LXRX Position: Q1 2026 in Review

OMERS Administration Corp reduced its Lexicon Pharmaceuticals (LXRX) stake by 61% in Q1 2026, selling an estimated $243K and leaving 106,800 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #948.

OMERS Administration Corp first reported a position in LXRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $315K in Q4 2025. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • OMERS Administration Corp held 106,800 shares of Lexicon Pharmaceuticals worth $167K as of Q1 2026.
  • OMERS Administration Corp sold 167,000 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $243K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #948 holding.
  • OMERS Administration Corp first reported a position in Lexicon Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Lexicon Pharmaceuticals position peaked at $315K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.